Sara Pilotto

5.8k citations
189 papers · 3.0k · 1 hit paper · h-index 29

Impact in

  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Cancer survivorship and care
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Cancer survivorship and care 29
    • Lung Cancer Research Studies 21
    • Cancer Immunotherapy and Biomarkers 20
    • Colorectal Cancer Treatments and Studies 9
    • Lung Cancer Treatments and Mutations 61
    • Lung Cancer Diagnosis and Treatment 19

Sara Pilotto

170 papers receiving 3.0k citations

Sara Pilotto's Hit Papers

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 2015 · 375 citations
3750+3+7Years since publication100200300

Peers

Sara Pilotto
Comparison fields: 5 of 111
  • Oncology 1.5k
  • Pulmonary and Respiratory Medicine 854
  • Cancer Research 390
  • Immunology 247
  • Molecular Biology 707
Replace Desmond Yip with:
Desmond Yip Australia
Brett Hughes Australia
Martin Früh Switzerland
Ellis Levine United States
Eliana Rulli Italy
Yuanyuan Zhao China
Karim Chamie United States
Alessandra Cassano Italy
Shannon N. Westin United States
Elie Rassy Lebanon
Sara Pilotto relative to Desmond Yip Australia Desmond Yip's profile →
Citations per field
00.5×2.6×
Desmond Yip · 1×
Citations per year

Countries citing papers authored by Sara Pilotto

Since Specialization
Citations

This map shows the geographic impact of Sara Pilotto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Pilotto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Pilotto more than expected).

Fields of papers citing papers by Sara Pilotto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Pilotto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Pilotto. The network helps show where Sara Pilotto may publish in the future.

Co-authors

The 25 scholars most cited alongside Sara Pilotto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sara Pilotto Line = papers co-authored together Sara Pilotto links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 189 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers
Hit paper breakdown →
2015375
2 2019126
3 2018120
4 2018102
5 201985
6 201975
7 201671
8 202065
9 201965
10 202064
11 201554
12 201853
13 201853
14 201852
15 201351
16 201446
17 201943
18 202141
19 201840
20 202040

About Sara Pilotto

Sara Pilotto is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Physiology, having authored 189 papers that have together received 3.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (61 papers), Cancer survivorship and care (29 papers), Lung Cancer Research Studies (21 papers), Cancer Immunotherapy and Biomarkers (20 papers), Lung Cancer Diagnosis and Treatment (19 papers), Cancer Genomics and Diagnostics (14 papers), Nutrition and Health in Aging (10 papers) and Colorectal Cancer Treatments and Studies (9 papers). The work is most often cited by research in Oncology (1.5k citations), Pulmonary and Respiratory Medicine (854 citations), Cancer Research (390 citations), Immunology (247 citations) and Molecular Biology (707 citations). Sara Pilotto has collaborated with scholars based in Italy, Spain and United States. Frequent co-authors include Emilio Bria, Michèle Milella, Giampaolo Tortora, Luisa Carbognin, Aldo Scarpa, Alice Avancini, Isabella Sperduti, Ilaria Trestini, Matteo Brunelli and Daniela Tregnago. Their work appears in journals such as Annals of Oncology, Critical Reviews in Oncology/Hematology, Journal of Clinical Oncology, Journal of Thoracic Oncology and Clinical Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact